Drug profile · INN
disopyramide phosphate
DISOPYRAMIDE PHOSPHATE
disopyramide phosphate (DISOPYRAMIDE PHOSPHATE) is a sodium channel alpha subunit blocker. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — disopyramide phosphate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
disopyramide phosphate (DISOPYRAMIDE PHOSPHATE) is a sodium channel alpha subunit blocker. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is disopyramide phosphate?
disopyramide phosphate (DISOPYRAMIDE PHOSPHATE) is a sodium channel alpha subunit blocker. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for disopyramide phosphate?
DISOPYRAMIDE PHOSPHATE is a marketed brand name for disopyramide phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of disopyramide phosphate?
disopyramide phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.